Editorials

Twins and fetal programming of blood pressure

BMJ 1999; 319 doi: https://doi.org/10.1136/bmj.319.7221.1313 (Published 20 November 1999) Cite this as: BMJ 1999;319:1313

Questioning the role of genes and maternal nutrition

  1. David A Leon, reader in epidemiology (d.leon@lshtm.ac.uk)
  1. London School of Hygiene and Tropical Medicine, London WC1E 7HT

    Papers pp 1325, 1330

    The weight of evidence linking reduced size at birth to raised blood pressure is now substantial1 and that for an increased risk of non-insulin dependent diabetes and coronary heart disease is increasingly convincing. Despite continuing scepticism,2 initial concerns that these statistical associations were due to chance, artefact, or confounding by factors in later life have been largely resolved. Attention is now turning towards elucidating underlying mechanisms and the public health importance of the “fetal origins” hypothesis.

    Over the past five years the biological plausibility that circumstances in utero can “program” the fetus, such that postnatal physiology and disease risk are altered, has been bolstered by evidence from animal models. Experimental manipulation of the environment of the fetus in utero, through modifying the maternal diet and other means, can undoubtedly have profound long term effects on structure and function.3

    The direct relevance of these animal models to humans has not been adequately assessed, particularly with regard to maternal nutrition Nevertheless, they provide an important counterpoint to the suggestion that genetic rather than environmental factors drive the association between impaired growth and later disease in humans.4 More direct human evidence about the possibility …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe